Healthy versus inflamed lung environments differentially affect mesenchymal stromal cells

Area of Science:

• Immunology
• Regenerative Medicine
• Cell Therapy

Background:

• Acute Respiratory Distress Syndrome (ARDS) involves severe immune dysregulation, inflammation, and coagulation.
• Mesenchymal stromal cell (MSC) therapies show promise for ARDS but clinical success is limited.
• Understanding MSC behavior in the ARDS inflammatory microenvironment is crucial.

Purpose of the Study:

• To compare how the lung environment in ARDS versus healthy individuals affects human bone marrow-derived MSC (hMSC) behavior.
• To investigate the impact of ARDS-associated inflammation on MSC function and potential therapeutic mechanisms.

Main Methods:

• Human bone marrow-derived MSCs (hMSCs) were exposed to bronchoalveolar lavage fluid (BALF) from ARDS patients and healthy volunteers.
• Evaluated hMSC viability, cytokine expression, gene expression, HLA expression, and coagulation/complement pathways.

Main Results:

• hMSCs exposed to healthy BALF showed upregulated pro-inflammatory, pro-coagulant, and MHC-related gene expression.
• These changes were less pronounced or reversed in hMSCs exposed to ARDS BALF.
• ARDS-associated lung inflammation may induce hMSC responses beneficial for cell survival and function.

Conclusions:

• The inflamed ARDS lung environment may promote hMSC survival and actions beneficial for therapy.
• These findings underscore the importance of understanding disease-specific microenvironments for optimizing MSC-based therapies.
• Further research is needed to elucidate how diverse disease contexts influence hMSC functions.